Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

CD82 Is a Marker for Prospective Isolation of Human Muscle Satellite Cells and Is Linked to Muscular Dystrophies.

Alexander MS, Rozkalne A, Colletta A, Spinazzola JM, Johnson S, Rahimov F, Meng H, Lawlor MW, Estrella E, Kunkel LM, Gussoni E.

Cell Stem Cell. 2016 Dec 1;19(6):800-807. doi: 10.1016/j.stem.2016.08.006. Epub 2016 Sep 15.

2.

POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations.

Di Costanzo S, Balasubramanian A, Pond HL, Rozkalne A, Pantaleoni C, Saredi S, Gupta VA, Sunu CM, Yu TW, Kang PB, Salih MA, Mora M, Gussoni E, Walsh CA, Manzini MC.

Hum Mol Genet. 2014 Nov 1;23(21):5781-92. doi: 10.1093/hmg/ddu296. Epub 2014 Jun 11.

3.

Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation.

Balasubramanian A, Kawahara G, Gupta VA, Rozkalne A, Beauvais A, Kunkel LM, Gussoni E.

FASEB J. 2014 Jul;28(7):2955-69. doi: 10.1096/fj.13-246470. Epub 2014 Mar 31.

4.

Mouse regenerating myofibers detected as false-positive donor myofibers with anti-human spectrin.

Rozkalne A, Adkin C, Meng J, Lapan A, Morgan JE, Gussoni E.

Hum Gene Ther. 2014 Jan;25(1):73-81. doi: 10.1089/hum.2013.126. Epub 2013 Dec 19.

5.

G-protein coupled receptor 56 promotes myoblast fusion through serum response factor- and nuclear factor of activated T-cell-mediated signalling but is not essential for muscle development in vivo.

Wu MP, Doyle JR, Barry B, Beauvais A, Rozkalne A, Piao X, Lawlor MW, Kopin AS, Walsh CA, Gussoni E.

FEBS J. 2013 Dec;280(23):6097-113. doi: 10.1111/febs.12529. Epub 2013 Oct 8.

6.

Human fetal skeletal muscle contains a myogenic side population that expresses the melanoma cell-adhesion molecule.

Lapan AD, Rozkalne A, Gussoni E.

Hum Mol Genet. 2012 Aug 15;21(16):3668-80. doi: 10.1093/hmg/dds196. Epub 2012 May 24.

7.

Inhibition of Sirtuin 2 with Sulfobenzoic Acid Derivative AK1 is Non-Toxic and Potentially Neuroprotective in a Mouse Model of Frontotemporal Dementia.

Spires-Jones TL, Fox LM, Rozkalne A, Pitstick R, Carlson GA, Kazantsev AG.

Front Pharmacol. 2012 Mar 12;3:42. doi: 10.3389/fphar.2012.00042. eCollection 2012.

8.

Apolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-β in human Alzheimer brain.

Jones PB, Adams KW, Rozkalne A, Spires-Jones TL, Hshieh TT, Hashimoto T, von Armin CA, Mielke M, Bacskai BJ, Hyman BT.

PLoS One. 2011 Jan 31;6(1):e14586. doi: 10.1371/journal.pone.0014586.

9.

Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice.

Rozkalne A, Hyman BT, Spires-Jones TL.

Neurobiol Dis. 2011 Mar;41(3):650-4. doi: 10.1016/j.nbd.2010.11.014. Epub 2010 Dec 4.

10.

Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels.

Tian D, Jacobo SM, Billing D, Rozkalne A, Gage SD, Anagnostou T, Pavenstädt H, Hsu HH, Schlondorff J, Ramos A, Greka A.

Sci Signal. 2010 Oct 26;3(145):ra77. doi: 10.1126/scisignal.2001200. Erratum in: Sci Signal. 2010;3(147):er11. Pavenstaedt, Hermann [corrected to Pavenstädt, Hermann].

11.

Calcineurin inhibition with systemic FK506 treatment increases dendritic branching and dendritic spine density in healthy adult mouse brain.

Spires-Jones TL, Kay K, Matsouka R, Rozkalne A, Betensky RA, Hyman BT.

Neurosci Lett. 2011 Jan 10;487(3):260-3. doi: 10.1016/j.neulet.2010.10.033. Epub 2010 Oct 21.

12.

Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation.

Wu HY, Hudry E, Hashimoto T, Kuchibhotla K, Rozkalne A, Fan Z, Spires-Jones T, Xie H, Arbel-Ornath M, Grosskreutz CL, Bacskai BJ, Hyman BT.

J Neurosci. 2010 Feb 17;30(7):2636-49. doi: 10.1523/JNEUROSCI.4456-09.2010.

13.

A single dose of passive immunotherapy has extended benefits on synapses and neurites in an Alzheimer's disease mouse model.

Rozkalne A, Spires-Jones TL, Stern EA, Hyman BT.

Brain Res. 2009 Jul 14;1280:178-85. doi: 10.1016/j.brainres.2009.05.045. Epub 2009 May 22.

14.

Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease.

Spires-Jones TL, Mielke ML, Rozkalne A, Meyer-Luehmann M, de Calignon A, Bacskai BJ, Schenk D, Hyman BT.

Neurobiol Dis. 2009 Feb;33(2):213-20. doi: 10.1016/j.nbd.2008.10.011. Epub 2008 Nov 6.

15.

Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease.

Freeman SH, Kandel R, Cruz L, Rozkalne A, Newell K, Frosch MP, Hedley-Whyte ET, Locascio JJ, Lipsitz LA, Hyman BT.

J Neuropathol Exp Neurol. 2008 Dec;67(12):1205-12. doi: 10.1097/NEN.0b013e31818fc72f.

16.

Two postprocessing techniques for the elimination of background autofluorescence for fluorescence lifetime imaging microscopy.

Jones PB, Rozkalne A, Meyer-Luehmann M, Spires-Jones TL, Makarova A, Kumar AT, Berezovska O, Bacskai BB, Hyman BT.

J Biomed Opt. 2008 Jan-Feb;13(1):014008. doi: 10.1117/1.2837169.

17.

Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.

Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, Koenigsknecht-Talboo J, Holtzman DM, Bacskai BJ, Hyman BT.

Nature. 2008 Feb 7;451(7179):720-4. doi: 10.1038/nature06616.

18.

Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ.

J Neurochem. 2007 Aug;102(4):1095-104. Epub 2007 Apr 30.

Supplemental Content

Loading ...
Support Center